1 |
A novel channelopathy in pulmonary arterial hypertension.
6
|
Ma L...Chung WK
|
23883380 |
2013 |
2 |
Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension.
6
|
Austin ED...Chung WK
|
22474227 |
2012 |
3 |
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension.
6
|
Nasim MT...Machado RD
|
21898662 |
2011 |
4 |
Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
6
|
Drake KM...Aldred MA
|
21920918 |
2011 |
5 |
A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension.
6
|
Shintani M...Matsuoka R
|
19211612 |
2009 |
6 |
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension.
6
|
Aldred MA...Trembath RC
|
16429403 |
2006 |
7 |
BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.
6
|
Sankelo M...Laitinen T
|
15965979 |
2005 |
8 |
Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.
6
|
Runo JR...Phillips JA
|
12446270 |
2003 |
9 |
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.
6
|
Humbert M...Morse JH
|
12358323 |
2002 |
10 |
Heritable Pulmonary Arterial Hypertension
6
|
Austin ED...Phillips JA
|
20301658 |
2002 |
11 |
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.
6
|
Machado RD...Nichols WC
|
11115378 |
2001 |
12 |
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
6
|
Thomson JR...Nichols WC
|
11015450 |
2000 |
13 |
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.
6
|
International PPH Consortium...Trembath RC
|
10973254 |
2000 |
14 |
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.
6
|
Deng Z...Knowles JA
|
10903931 |
2000 |
15 |
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
6
|
Hanks SK...Hunter T
|
3291115 |
1988 |
16 |
Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension: extended study results.
61
|
Aypar E...Ertugrul I
|
32290885 |
2020 |
17 |
Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.
61
|
Ogawa A...Matsubara H
|
29548663 |
2018 |
18 |
Clinical efficacy and safety of switch from bosentan to macitentan in children and young adults with pulmonary arterial hypertension.
61
|
Aypar E...Ertugrul I
|
29233198 |
2018 |
19 |
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
61
|
Caravita S...Vachiery JL
|
29920539 |
2018 |
20 |
Survival of Japanese Patients With Idiopathic/Heritable Pulmonary Arterial Hypertension.
61
|
Ogawa A...Matsubara H
|
28267959 |
2017 |
21 |
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: real-world insights.
61
|
Dardi F...Galie N
|
26022952 |
2015 |
22 |
Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan.
61
|
Ogawa A...Matsubara H
|
24530872 |
2014 |
23 |
Treatment of idiopathic/hereditary pulmonary arterial hypertension.
61
|
Matsubara H...Ogawa A
|
25082294 |
2014 |
24 |
STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
61
|
Barst RJ...STARTS-2 Investigators
|
24637559 |
2014 |